MENU
LXEO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lexeo Therapeutics (LXEO) Ownership - Who owns Lexeo Therapeutics?
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more
Profile
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
89.96M
P/E Ratio
N/A
Total Cash
157.02M
Projected Growth
N/A
Total Debt
10.4M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
4.73
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
LXEO
Capitalization
90M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
157M
Total Cash/Share
4.73
Total Debt
10.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
139M
P/B Ratio
0.77
Cash Flow
N/A
Earnings
-12.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
5.95
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-84.47M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-75.77
Shares Held By Institutions
294M
Shares Outstanding - Current
33.2M
Total Liabilities
34.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
-58.815
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com